ENG and neoplasm: The crystal structure of the ENG in complex with its ligand bone morphogenetic protein 9 (BMP9) shows that the interface between ENG and BMP9 contains residues mutated in HHT1 and overlaps with the epitope of tumor-suppressing anti-ENG monoclonal TRC10540.